23andMe Holding Co. - Common Stock (NQ:ME)

0.6063 UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 23andMe Holding Co. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Top 5 Health Care Stocks That May Explode In Q3 ↗

September 06, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Why Olin Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

September 01, 2023

Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) surged 181.1% to $3.63. TradeUP Acquisition Corp. (NASDAQ: UPTD) gained 148.5% to $18.14.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 01, 2023

Via Benzinga

23andMe Holding's Return On Capital Employed Overview ↗

May 26, 2023

Via Benzinga

Recap: 23andMe Holding Q4 Earnings ↗

May 25, 2023

Via Benzinga

23andMe Holding's Earnings Outlook ↗

May 24, 2023

Via Benzinga

Why Dell Technologies Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket ↗

September 01, 2023

Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) rose 53.4% to $0.2147 in pre-market trading after the company announced it received an Underwriting Clearance Notice for a $70 million coupon.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 31, 2023

Via Benzinga

23andMe Granted New FDA Clearance to Report Additional BRCA Variants

August 31, 2023

From 23andMe, Inc.

Via GlobeNewswire

Better AI Biotech Stock: Recursion Pharmaceuticals vs. 23andMe ↗

August 25, 2023

Both businesses have a lot to prove.

Via The Motley Fool

Topics Artificial Intelligence

Why 23andMe Holding Stock Plummeted by 13% Today ↗

August 09, 2023

Investors reacted sharply and not well to the company's inaugural set of fiscal 2024 earnings.

Via The Motley Fool

23andMe Reports FY2024 First Quarter Financial Results

August 08, 2023

From 23andMe, Inc.

Via GlobeNewswire

23andMe to Report FY2024 First Quarter Financial Results

July 25, 2023

From 23andMe, Inc.

Via GlobeNewswire

23andMe Releases New FDA-Cleared Genetic Report on Simvastatin, a Commonly Prescribed Statin

July 20, 2023

From 23andMe, Inc.

Via GlobeNewswire

23andMe Releases New Report Revealing Genetic Likelihood of Experiencing Panic Attacks

June 21, 2023

With millions of Americans experiencing mental health symptoms, 23andMe+ members now have exclusive access to four mental health reports to help determine their genetic likelihood of having one of...

From 23andMe, Inc.

Via GlobeNewswire

3 Gene Testing Stocks to Buy Before They Take Off ↗

June 17, 2023

The future of gene testing is bright thanks to an aging population. Here are three companies leading the industry.

Via InvestorPlace

23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results

May 25, 2023

From 23andMe, Inc.

Via GlobeNewswire

Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics ↗

May 23, 2023

Neither has a traditional business model, but that could be an asset for both.

Via The Motley Fool

3 Key Biotech Trends for 2023 And Beyond ↗

May 19, 2023

New opportunities are becoming apparent, but so are fresh risks in the biotech field.

Via The Motley Fool

Hero or Zero? 3 High-Risk Penny Stocks to Make You Rich … or Broke. ↗

May 19, 2023

Explore the world of high-risk penny stocks, with their potential for significant returns, as we analyze three speculative opportunities.

Via InvestorPlace

New 23andMe survey reveals nine out of ten physicians in the U.S. believe genetics play an important part of a patient’s complete health picture

May 16, 2023

From 23andMe, Inc.

Via GlobeNewswire

3 Personalized Medicine Stocks to Buy for Long-Time Returns ↗

May 15, 2023

Personalized medicine is the future of medicine. Here are three personalized medicine stocks to invest in so you don't miss out.

Via InvestorPlace

23andMe to Report FY2023 Fourth Quarter and Full Year Financial Results

May 11, 2023

From 23andMe Holding Co.

Via GlobeNewswire

23andMe Releases New Report Revealing Likelihood of Developing Lupus

May 09, 2023

23andMe+ members can now gain insights on the chronic autoimmune condition

From 23andMe Holding Co.

Via GlobeNewswire

Reza Afkhami Joins 23andMe as Chief Corporate Development Officer

May 08, 2023

Afkhami joins 23andMe with more than 20 years of experience in corporate development and strategy

From 23andMe Holding Co.

Via GlobeNewswire

BELLUS Health, Sunrun And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session ↗

April 18, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

23andMe Announces Phase 1 Results from the First-in-Human Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1

April 14, 2023

From 23andMe Holding Co.

Via GlobeNewswire

Morehouse School of Medicine, Sickle Cell Foundation of Georgia and 23andMe Launch Sickle Cell Carrier Status Awareness Program

April 11, 2023

From 23andMe Holding Co.

Via GlobeNewswire

23andMe Aims To Raise Awareness of Lipoprotein(a), a Little-Known Genetic Risk Factor for Cardiovascular Disease

March 24, 2023

Company teams up with Novartis on Lipoprotein(a) education for 23andMe customers

From 23andMe Holding Co.

Via GlobeNewswire

3 Key Ways That Artificial Intelligence Will Disrupt Biotech Stocks ↗

March 22, 2023

Biotechs with an AI strategy are likely to be the first to flourish from the disruptions.

Via The Motley Fool

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.